These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 34375485
1. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia. Silva-Spínola A, Lima M, Leitão MJ, Durães J, Tábuas-Pereira M, Almeida MR, Santana I, Baldeiras I. Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW, Keshavan A, Fox NC, Warren JD, Schott JM, Zetterberg H, Rohrer JD. Alzheimers Res Ther; 2018 Aug 16; 10(1):79. PubMed ID: 30111356 [Abstract] [Full Text] [Related]
13. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. Meeter LHH, Vijverberg EG, Del Campo M, Rozemuller AJM, Donker Kaat L, de Jong FJ, van der Flier WM, Teunissen CE, van Swieten JC, Pijnenburg YAL. Neurology; 2018 Apr 03; 90(14):e1231-e1239. PubMed ID: 29514947 [Abstract] [Full Text] [Related]
14. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, Kramer JH, Rabinovici G, Ahlijanian M, Miller BL, Seeley W, Grinberg LT, Rosen H, Meredith J, Boxer AL. Ann Neurol; 2014 Jan 03; 75(1):116-26. PubMed ID: 24242746 [Abstract] [Full Text] [Related]
15. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation. Toft A, Roos P, Jääskeläinen O, Musaeus CS, Henriksen EE, Johannsen P, Nielsen TT, Herukka SK, Hviid Simonsen A, Nielsen JE. Dement Geriatr Cogn Disord; 2020 Jan 03; 49(6):533-538. PubMed ID: 33626531 [Abstract] [Full Text] [Related]
16. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia. Hsiao-Nakamoto J, Chiu CL, VandeVrede L, Ravi R, Vandenberg B, De Groot J, Tsogtbaatar B, Fang M, Auger P, Gould NS, Marchioni F, Powers CA, Davis SS, Suh JH, Alkabsh J, Heuer HW, Lago AL, Scearce-Levie K, Seeley WW, Boeve BF, Rosen HJ, Berger A, Tsai R, Di Paolo G, Boxer AL, Bhalla A, Huang F, ALLFTD Consortium. bioRxiv; 2024 Feb 12. PubMed ID: 38405775 [Abstract] [Full Text] [Related]
18. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H. Neurology; 2016 Sep 27; 87(13):1329-36. PubMed ID: 27581216 [Abstract] [Full Text] [Related]